The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation
Open accessAbstract
Head and neck squamous cell carcinoma (HNSCC) clearly involves activation of the Akt mammalian target of rapamycin (mTOR) signalling pathway. However, the effectiveness of treatment with the mTOR inhibitor rapamycin is often limited by chemoresistance. Melatonin suppresses neoplastic growth via different mechanisms in a variety of tumours. In this study, we aimed to elucidate the effects of melatonin on rapamycin‐induced HNSCC cell death and to identify potential cross‐talk pathways. We analysed the dose‐dependent effects of melatonin in rapamycin‐treated HNSCC cell lines (Cal‐27 and SCC‐9). These cells were treated with 0.1, 0.5 or 1 mmol/L melatonin combined with 20 nM rapamycin. We further examined the potential synergistic effects of melatonin with rapamycin in Cal‐27 xenograft mice. Relationships between inhibition of the mTOR pathway, reactive oxygen species (ROS), and apoptosis and mitophagy reportedly increased the cytotoxic effects of rapamycin in HNSCC. Our results demonstrated that combined treatment with rapamycin and melatonin blocked the negative feedback loop from the specific downstream effector of mTOR activation S6K1 to Akt signalling, which decreased cell viability, proliferation and clonogenic capacity. Interestingly, combined treatment with rapamycin and melatonin‐induced changes in mitochondrial function, which were associated with increased ROS production, increasing apoptosis and mitophagy. This led to increase cell death and cellular differentiation. Our data further indicated that melatonin administration reduced rapamycin‐associated toxicity to healthy cells. Overall, our findings suggested that melatonin could be used as an adjuvant agent with rapamycin, improving effectiveness while minimizing its side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Wise, D. R., Ward, P. S., Shay, J. E. S., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo, R. G., Simon, M. C., & Thompson, C. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117773108 · Cited by 975
Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy
Sentelle, R. D., Senkal, C. E., Jiang, W., Ponnusamy, S., Gencer, S., Panneer Selvam, S., Ramshesh, V. K., Peterson, Y. K., Lemasters, J. J., Szulc, Z. M., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1059 · Cited by 539
Yung, H. W., Charnock-Jones, D. S., & Burton, G. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017894 · Cited by 158
Evaluation of Small Intestine Grafts Decellularization Methods for Corneal Tissue Engineering
Oliveira, A. C., Garzón, I., Ionescu, A. M., Carriel, V., Cardona, J. D. L. C., González-Andrades, M., Pérez, M. D. M., Alaminos, M., & Campos, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066538 · Cited by 114
Self-citationTissue Fixation and Processing for the Histological Identification of Lipids
Carriel, V., Campos, F., Aneiros-Fernández, J., & Kiernan, J. A. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6788-9_14 · Cited by 34
Self-citation
Cited by
Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells
Tan, D.-X., & Reiter, R. J. (2019) · Melatonin Research · doi:10.32794/mr11250011 · Cited by 172
“reports documented the inhibitory action of melatonin on mitophagy (157) and others report that melatonin promotes mitophagy depending on the study conditions and experimental models (84, 158, 159).”
BackgroundSelf-citationRepurposing disulfiram to induce OSCC cell death by cristae dysfunction promoted autophagy
Wang, Z., Jiang, H., Cai, L., Ji, N., Zeng, X., Zhou, Y., Shen, Y., & Chen, Q. (2021) · Oral Diseases · doi:10.1111/odi.13652 · Cited by 15
Self-citation
Metadata
- Authors
- Shen, Y., Guerra‐Librero, A., Fernandez‐Gil, B. I., Florido, J., García‐López, S., Martinez‐Ruiz, L., Mendivil‐Perez, M., Soto‐Mercado, V., Acuña‐Castroviejo, D., Ortega‐Arellano, H., Carriel, V., Diaz‐Casado, M. E., Reiter, R. J., Rusanova, I., Nieto, A., López, L. C., & Escames, G.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2018-01-09
- Volume
- 64
- Issue
- 3
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W2771691812
- Cited by
- 170
- References
- 8
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation. https://app.cochat.ai/papers/10.1111/jpi.12461
- The paper
- Shen, Y., Guerra‐Librero, A., Fernandez‐Gil, B. I., Florido, J., García‐López, S., Martinez‐Ruiz, L., Mendivil‐Perez, M., Soto‐Mercado, V., Acuña‐Castroviejo, D., Ortega‐Arellano, H., Carriel, V., Diaz‐Casado, M. E., Reiter, R. J., Rusanova, I., Nieto, A., López, L. C., & Escames, G. (2018). Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation. Journal of Pineal Research. https://doi.org/10.1111/jpi.12461
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.